CHITOSHIBA MEDICS LTD

CHITOSHIBA MEDICS LTD
Contents Page
For the year ended 31 October 2025

Accountants' Report	1
Statement of Financial Position	2
Notes to the Financial Statements	3

CHITOSHIBA MEDICS LTD Accountants' Report For the year ended 31 October 2025
Accountant’s report You consider that the company is exempt from an audit for the year ended 31 October 2025 . You have acknowledged, on the balance sheet, your responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These responsibilities include preparing accounts that give a true and fair view of the state of affairs of the company at the end of the financial year and of its profit or loss for the financial year. In accordance with your instructions, we have prepared the accounts which comprise the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the accounting records of the company and on the basis of information and explanations you have given to us. We have not carried out an audit or any other review, and consequently we do not express any opinion on these accounts. NEWINTON ACCOUNTANCY LTD 31 October 2025 .................................................... NEWINTON ACCOUNTANCY LTD 22 July 2026 1

CHITOSHIBA MEDICS LTD
Accountants' Report
For the year ended 31 October 2025

Accountant’s report
You consider that the company is exempt from an audit for the year ended 31 October 2025 . You have acknowledged, on the balance sheet, your responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These responsibilities include preparing accounts that give a true and fair view of the state of affairs of the company at the end of the financial year and of its profit or loss for the financial year.
In accordance with your instructions, we have prepared the accounts which comprise the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the accounting records of the company and on the basis of information and explanations you have given to us.
We have not carried out an audit or any other review, and consequently we do not express any opinion on these accounts.
NEWINTON ACCOUNTANCY LTD
31 October 2025

....................................................

NEWINTON ACCOUNTANCY LTD

22 July 2026

1

CHITOSHIBA MEDICS LTD
Statement of Financial Position
As at 31 October 2025

	Notes	2025 £	2024 £
Fixed assets
Investments	3	48,000	0
		48,000	0
Current assets
Debtors		12,767	3
Cash at bank and in hand		12,467	52,022
		25,234	52,025
Creditors: amount falling due within one year		(13,607)	(21,703)
Net current assets		11,627	30,322

Total assets less current liabilities		59,627	30,322
Net assets		59,627	30,322

Capital and reserves
Called up share capital	4	1	1
Profit and loss account		59,626	30,321
Shareholders' funds		59,627	30,322

For the year ended 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).

The financial statements were approved by the director on 22 July 2026 and were signed by:

-------------------------------
Chinyere Iloba
Director

2

CHITOSHIBA MEDICS LTD
Notes to the Abridged Financial Statements
For the year ended 31 October 2025

General Information

CHITOSHIBA MEDICS LTD is a private company, limited by shares, registered in England and Wales, registration number 14415580, registration address 34 WILKS ROAD, DARTFORD ENGLAND, DA2 6FT.

The presentation currency is £ sterling.

1.

Accounting policies

Significant accounting policies

Statement of compliance

These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.

Basis of preparation

The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.

The financial statements are prepared in sterling which is the functional currency of the company.

Turnover

Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.

2.	Average number of employees Average number of employees during the year was 2 (2024 : 0).

3.

Investments

Cost	Other investments other than loans	Total
	£	£
At 01 November 2024	-	-
Additions	48,000	48,000
Disposals	-	-
At 31 October 2025	48,000	48,000

4.

Share Capital

Allotted, called up and fully paid	2025 £		2024 £
1 Class A share of £1.00 each	1		1
	1		1

3

Registered Number: 14415580
England and Wales
CHITOSHIBA MEDICS LTD

Abridged Accounts

Period of accounts Start date: 01 November 2024 End date: 31 October 2025